Effectiveness of Pulsed Electromagnetic Fields on Bone Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Technology context Clinical PEMF bone-healing devices used under medical supervision - not consumer wellness mats
Finding: Pooled across 14 randomised trials, PEMF increased fracture healing rate from 64.3% to 79.7% (RR 1.22, 95% CI 1.10-1.35) and relieved pain (SMD -0.49, 95% CI -0.88 to -0.10), rated moderate quality evidence.
Main limitation: These were clinical bone-healing devices used at defined parameters for diagnosed fractures under supervision - a different device class from a consumer wellness mat, and heterogeneity was high.
Executive summary
This is the best evidence that exists anywhere in the PEMF category, and understanding exactly what it covers is the key to reading the category honestly.
The reviewers searched nine databases including Chinese-language sources for randomised controlled trials published before July 2019 comparing any form of pulsed electromagnetic field against sham in patients with fractures. Twenty-two studies with 1,468 participants were eligible.
Pooled results from 14 studies covering 1,131 participants showed a healing rate of 79.7% (443 of 556) in the PEMF group against 64.3% (370 of 575) in the control group - a relative risk of 1.22 (95% CI 1.10-1.35, I² = 48%).
PEMF also relieved pain (SMD -0.49, 95% CI -0.88 to -0.10, I² = 60%) and accelerated healing time (SMD -1.01, 95% CI -2.01 to -0.00, I² = 90%).
The authors graded the evidence explicitly: moderate quality evidence that PEMF increased healing rate and relieved pain of fracture, and very low quality evidence that it accelerated healing time. They call for larger, higher quality trials and preclinical studies of optimal frequency, amplitude and duration parameters.
Every one of those trials used a clinical device, at defined parameters, in a patient with a diagnosed fracture, under medical supervision. None of them tested a wellness mat.
Why this research matters
Bone healing is the application with the longest regulatory history in this field and the only one with a substantial randomised trial literature. It is therefore the correct benchmark against which every other PEMF claim should be judged.
It also demonstrates what good evidence in this category looks like - and by contrast, how little of it exists for the consumer products that dominate the market.
Study design
- Study type
- Systematic review with meta-analysis of randomised controlled trials
- Databases searched
- CNKI, Wan Fang, VIP, EMbase, PubMed, CENTRAL, Web of Science, Physiotherapy Evidence Database, Open Grey
- Publication window
- Before July 2019, in English or Chinese
- Studies eligible
- 22
- Total participants
- 1,468
- Studies pooled for healing rate
- 14 (1,131 participants)
- Population
- Patients with fractures
- Intervention
- Any form of pulsed electromagnetic field
- Comparator
- Sham
- Primary outcomes
- Healing rate, pain, healing time
- Analysis methods
- Mantel-Haenszel for healing rate; inverse variance for pain and healing time
- Evidence grading
- Moderate quality for healing rate and pain; very low quality for healing time
- Device parameters
- Frequency, amplitude and duration varied; the authors call for studies of optimal parameters
What the researchers found
Healing rate. 79.7% (443/556) in the PEMF group versus 64.3% (370/575) in the control group. Relative risk 1.22 (95% CI 1.10-1.35, I² = 48%), by Mantel-Haenszel analysis. Graded moderate quality evidence.
Pain. Standardised mean difference -0.49 (95% CI -0.88 to -0.10, I² = 60%), by inverse variance analysis. Graded moderate quality evidence.
Healing time. Standardised mean difference -1.01 (95% CI -2.01 to -0.00, I² = 90%). Graded very low quality evidence. Note that the upper confidence bound reaches 0.00, and heterogeneity of 90% is very high.
The authors conclude that larger and higher quality randomised controlled trials, and preclinical studies of optimal frequency, amplitude and duration parameters, are needed.
What the results mean
A relative risk of 1.22 means fractures in the PEMF groups healed at about 1.22 times the rate of controls - in absolute terms, roughly 80% versus 64%. That is a clinically meaningful difference for a diagnosed fracture, and the confidence interval excludes 1.0.
The pain effect is modest. An SMD of -0.49 with an interval running from -0.88 to -0.10 is a small to moderate effect whose lower bound is close to nothing.
The healing-time result should be treated as unreliable. Heterogeneity of 90% means the included studies disagreed profoundly, the confidence interval touches zero, and the authors themselves graded it very low quality.
The essential translation for a buyer: this supports a prescription medical device for a diagnosed fracture. It says nothing about a mat bought for general wellbeing.
What this study does not prove
- It does not establish any benefit for consumer PEMF wellness mats or pads. Every trial used clinical bone-healing devices at defined parameters.
- It does not support claims about sleep, energy, circulation, detoxification, recovery, or general wellbeing - none were studied.
- It does not establish optimal frequency, amplitude or duration; the authors identify this as an open question.
- The healing-time finding is graded very low quality with 90% heterogeneity and should not be cited as established.
- Findings in patients with diagnosed fractures under supervision do not generalise to healthy people using equipment unsupervised.
- It does not establish long-term outcomes beyond fracture healing.
Evidence strength
Systematic review with meta-analysis of randomised controlled trials
Meta-analysis of randomised controlled trials is the strongest evidence design available short of a single large definitive trial, and this review adds formal grading of evidence strength for each outcome.
That grading is what makes it trustworthy: the authors rated the healing-rate and pain findings as moderate quality evidence and the healing-time finding as very low quality, rather than presenting all three as equally solid.
Strengths and limitations
Strengths
- Meta-analysis restricted to randomised controlled trials with sham comparators.
- Large total sample at 1,468 participants across 22 studies.
- Nine databases searched including Chinese-language sources, reducing language bias.
- Formal grading of evidence strength separately for each outcome.
- Independent duplicate data extraction by two investigators.
- Reports heterogeneity for every pooled outcome.
- Clinically meaningful endpoint - actual fracture healing, not a surrogate marker.
Limitations
- Substantial heterogeneity: 48% for healing rate, 60% for pain, 90% for healing time.
- Device parameters varied widely across trials and were not standardised.
- The healing-time estimate is graded very low quality and its confidence interval reaches 0.00.
- Search closed in July 2019.
- Blinding quality of sham devices across included trials not reported in the source abstract.
- Restricted to fracture populations, limiting generalisability to any other use.
Does this apply to the equipment IMPERVITA sells?
This evidence concerns FDA-cleared and clinical-grade bone growth stimulation devices used for diagnosed fractures under medical supervision. It does not transfer to consumer PEMF wellness mats or pads.
The differences are not marginal. Clinical bone-healing devices operate at defined field parameters validated for that indication, are prescribed for a specific diagnosis, and are used under supervision for a defined course. A consumer wellness mat is a different device class, generally at different intensities, marketed for general wellbeing rather than any diagnosis.
Under the FDA's general wellness framework, a product making no disease treatment claim sits outside the medical device pathway - which is precisely why a wellness mat has not been required to demonstrate what these trials demonstrated.
If a seller cites fracture-healing research on a wellness mat page, that is a category error, and it is the most common one in this field.
Evidence in context
The picture became less favourable after this review, not more. A 2024 systematic review update examining acute bone fractures included three randomised controlled trials with 197 patients and found that none demonstrated significant effects of pulsed electromagnetic fields on the acute bone healing process, with contradictory results on pain. Its authors concluded the update does not support the use of PEMF for improving bone healing in acute fractures.
That is a direct tension with this meta-analysis, and a buyer should know about it. The two differ in inclusion window and population, but the honest summary is that the strongest application in this field is now contested rather than settled.
For osteoarthritis, a 2022 umbrella review of systematic reviews found most concurrence for short-term pain reduction, while noting heterogeneous treatment schemes, low sample sizes and suboptimal designs from which no sufficient proof of efficacy can be derived.
Related research
- Effects of pulsed electromagnetic fields on bone fractures: a systematic review update The 2024 update that found no significant effect on acute fracture healing - the direct counterweight to this meta-analysis.
- Effects of pulsed electromagnetic field therapy on outcomes associated with osteoarthritis: a systematic review of systematic reviews Umbrella review of PEMF for osteoarthritis, reporting most concurrence on pain but no sufficient proof of efficacy.
- General wellness: policy for low risk devices - guidance for industry and FDA staff FDA guidance defining where a general wellness product ends and a regulated medical device begins - the distinction this entry turns on.
- Health products compliance guidance FTC standard for substantiating health claims, directly relevant to citing clinical-device evidence for consumer products.
Practical buyer relevance
This entry exists mainly to arm you against one specific sales move: citing fracture-healing research to sell a wellness mat.
The first question to ask any PEMF seller is whether the device is an FDA-cleared medical device or a general wellness product, and to ask for that in writing. 'FDA registered' and 'FDA listed' are administrative filings, not reviews of safety or effectiveness. 'FDA approved' is a different and more demanding pathway that rarely applies here.
The second is what field intensity the device produces, in microtesla or gauss, and at what point in the mat it was measured. Field strength falls off rapidly with distance from the coil, and this is the specification most often absent from consumer marketing.
If a wellness mat is what you want, buy it for what it is - a low-footprint, passive, generally well-tolerated addition to a routine - and not on the strength of trials it has nothing to do with.
Safety context
Pulsed electromagnetic fields can interact with implanted electronic devices. Equipment must not be used by anyone with a pacemaker, implanted defibrillator, insulin pump, cochlear implant or other active implant, and manufacturer contraindication lists should be read before purchase rather than after delivery.
People who are pregnant, have epilepsy, or have an active malignancy may require guidance from a qualified healthcare professional before use. The trials underlying the evidence in this category were conducted under clinical supervision for diagnosed conditions, which is a different context from unsupervised general wellness use.
Full source record
- Title
- Effectiveness of Pulsed Electromagnetic Fields on Bone Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Authors
- Peng L, Fu C, Xiong F, et al.
- Organization
- Sichuan University West China Hospital
- Publication
- Bioelectromagnetics
- Year
- 2020
- Volume / issue / pages
- Volume 41, issue 5, pages 323-337
- PMID
- 32495506
- Study type
- Systematic review with meta-analysis of randomised controlled trials
- Sample size
- 22 studies, 1,468 participants; 14 studies with 1,131 participants pooled for healing rate
- Population
- Patients with fractures, treated in clinical settings
- Topic
- PEMF, regulatory
- Document type
- Meta-analysis
- Technology context
- Clinical PEMF bone-healing devices used under medical supervision - not consumer wellness mats
- Related equipment context
- PEMF
- Source last verified
- 19 August 2026
References
- Effectiveness of pulsed electromagnetic fields on bone healing: a systematic review and meta-analysis of randomized controlled trials
- Effects of pulsed electromagnetic fields on bone fractures: a systematic review update
- Effects of pulsed electromagnetic field therapy on outcomes associated with osteoarthritis: a systematic review of systematic reviews
- General wellness: policy for low risk devices - guidance for industry and FDA staff
- Health products compliance guidance
Information provided by IMPERVITA is for educational and general wellness purposes and is not intended to replace professional medical advice, diagnosis, or treatment.
